Glen Bradbury, Manager (ACVM Appraisals and Programmes) of the Ministry for Primary Industries
(MPI), acting under delegated authority from the
Director-General of MPI, gives notice, under section
14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 ("the Act"), that the following application has been made to register a trade name
product under section 9(1) of the Act:
Trade Name: Penethaject Inj Susp (33% Penethacillin)
Active Ingredient and Concentration:
Penethamate hydriodide 333.3mg
Formulation Type: Suspension concentrate
General Use Claims: For the treatment and control of infections caused by penicillin-sensitive Gram-positive bacteria and for mastitis in cattle.
Any person may make a written submission to the
director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
(a) must state in full the reasons for making the submission; and
(b) may state any decision sought on that application; and
(c) must be received by the director-general no later than 30 working days after the date of notification
in the New Zealand Gazette.
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
(a) where submissions on this application are to be sent; and
(b) where requests for copies of the public information relating to the application can be sent; and
(c) where public information relating to the application can be viewed; and
(d) the director-general’s address for service:
ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
Bayer NZ Limited, 3 Argus Place, Hillcrest, Auckland 0627. Postal Address: PO Box 2825, Shortland Street, Auckland 1140.
Dated at Wellington this 7th day of February 2013.
GLEN BRADBURY, Manager (ACVM Appraisals and Programmes), Ministry for Primary Industries (acting under delegated authority).